In the context of NAFLD, elevated expression of METTL3 in liver tissues correlates with an increased likelihood of disease progression to cirrhosis and hepatocellular carcinoma [15, 141, 287]. Here, METTL3 is linked to metabolic dysfunction-associated steatotic liver disease.